To every person on this team — sales, account services, operations, and partners — the wins we're celebrating today are a result of everyone showing up and delivering.
Four forces are reshaping how pharma buys HCP media — each one plays to our strengths.
$12B+ in pharma digital spend — only a fraction reaches the right physician, at the right moment, with proof. That's the gap Equals 5 was built to close.
FY2026 through May 11 · Live Pipedrive data · 92 deals closed · Q1 our strongest quarter ever
Campaigns delivered and billed · Jan–Apr 2026 · Q1 our strongest earned quarter ever
Three scenarios · Revenue goal includes signings + high-probability open deals
Live Pipedrive · Active Client label · Oncology · Rare Disease · Neurology · Immunology · Agency Partners










Jan 1 – May 4, 2026 · Won deals · Live Pipedrive data · $9.96M tracked across 60 deals
Brand new client relationships — first deal closed Q4 2025 or later.
Social + programmatic at the core. Strategic add-ons extend it when the brief demands it.
Reach the right patient. Prime the right physician. Measure the script.
Approved working relationships — right tool for the right situation
Three rules. Every deal. Every time.
Back in 10 minutes — Act 3 is next: How We Win
Five companies compete for the same pharma HCP media budgets. Here's how they stack up.
AI-driven HCP DSP. Strong programmatic display and CTV — but no native social activation. Head-to-head at Amgen: EQ5 delivered 6.5× higher CTR.
Division of Internet Brands (WebMD). Strong EHR/endemic reach — 4.2M NPI foundation — but no NPI-targeted social. Dominates white coat moments, not news feeds.
Largest pharma data company moving into media activation. Massive NPI database — but no native social execution. Activates through third-party channels; data strength doesn't equal campaign performance.
Part of Real Chemistry. Data company — builds NPI audiences but has no activation platform. DTC-first; HCP secondary. Clients stitch their own channel buy.
WPP-owned, largest pharma media agency. Quotes $65 CPM — but that's PLD only. All-in is ~$140 vs. our $185. The gap is $45 — and they buy us because they can't replicate it.
Why we sell direct — and who in pharma you need to own.
AI that continuously monitors what matters — and surfaces exactly what you need to know, exactly when you need it. No hunting required.
AI monitors relevant data sources around the clock — surfacing performance insights, highlights, and the details that drive decisions. No hunting required.
The intelligence layer for the team — pipeline, competitive, territory news, rates, and tools. Surfaced for you. Live now.
Every EQ5 Agent experience is personalized — the right data, for the right person, at the right moment. One link. Always current.